New study tracks COPD patients on trimbow: better breathing or just better compliance?
NCT ID NCT03963167
First seen Mar 07, 2026 · Last updated May 22, 2026 · Updated 14 times
Summary
This study followed 661 Italian adults with moderate to severe COPD who were prescribed the Trimbow inhaler. Researchers wanted to see if the treatment improved patients' health status and how well they stuck to their medication routine over 12 months. The study did not test a new drug but observed real-world use of an existing one.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COPD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fondazione Policlinico Gemelli
Rome, Italy
Conditions
Explore the condition pages connected to this study.